A Contemporary Prostate Biopsy Risk Calculator Based on Multiple Heterogeneous Cohorts

Conclusions The PBCG model should be used in place of the PCPTRC for prediction of prostate biopsy outcome. Patient summary A contemporary risk tool for outcomes on prostate biopsy based on the routine clinical risk factors is now available for informed decision-making. A North American multicohort-based risk tool for predicting prostate cancer outcomes on biopsy has been developed and outperformed a leading North American risk tool in validation. It is now available online for patients and their providers.
Source: European Urology - Category: Urology & Nephrology Source Type: research